Sign in
VERU Stock Price, Chart, Stats & News
Veru Inc.
Save
Veru Inc. (VERU) does not currently pay a dividend.
41.09M
Market cap
–
Current P/E
117.65x
Forward P/E
VERU chart
Fundamentals
Gross margin | -46.72% |
Operating margin | -8065.09% |
Pretax margin | -7776.79% |
Net margin | -7736.26% |
Effective tax rate | – |
ROA | -40.18% |
ROE | -83.24% |
D/E | 0.08x |
Interest coverage ratio | – |
VERU valuation
P/E | – |
P/S | 135.78x |
P/B | 1.14x |
P/CF | -1.71x |
P/FCF | -1.35x |
P/OCF | -1.71x |
PEG | -0.47x |
EV multiple | -6.33x |
About
Veru Inc. operates as a biopharmaceutical firm primarily dedicated to advancing novel therapeutic agents for various types of cancer. Commercially, Veru markets the FC2 internal condom, designed to offer dual protection against both unplanned pregnancies and the transmission of sexually transmitted infections. This product is distributed globally to a diverse clientele, including governmental health departments, UN organizations, non-profit entities, and commercial distributors.
Similar securities
Based on sector and market capitalization
Report issue